TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
AMGN

Amgen Inc

Healthcare · Drug Manufacturers - General

406.10$ -1.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

Amgen Inc (AMGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 10,054 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AMGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
6,903 8,196 7,447 8,388 8,503 9,086 8,149 9,167 9,557 9,896 8,618 10,054 38,125
1,806 3,112 3,200 3,236 3,310 3,112 2,968 3,011 3,082 1,790 2,744 2,811 10,427
5,097 5,084 4,247 5,152 5,193 5,974 5,181 6,156 6,475 8,106 5,874 7,243 27,698
1,079 1,534 1,343 1,447 1,450 1,724 1,486 1,744 1,900 2,151 1,719 1,868 7,638
1,353 1,627 1,808 1,785 1,625 891 1,687 1,691 1,720 1,952 1,602 1,745 7,019
3,076 3,813 3,256 3,243 3,146 3,663 4,003 3,512 3,949 4,164 3,208 3,729 15,050
2,021 1,271 991 1,909 2,047 2,311 1,178 2,644 2,526 3,942 2,666 3,514 12,648
759 821 824 808 776 747 723 708 685 653 657 673 2,668
1,947 852 -68 794 3,101 782 1,973 1,568 3,921 1,514 2,084 2,768 10,287
217 85 45 48 271 155 243 136 705 181 265 393 1,544
1,730 767 -113 746 2,830 627 1,730 1,432 3,216 1,333 1,819 2,375 8,743
3,601 3,053 2,155 3,002 5,273 2,926 4,083 3,617 5,913 3,299 3,857 3,441 16,510

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?